Peggy GANDIA

Documents

Présentation

Publications

	Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis Justine Madaule , Félix Valenzuela , Marie Mittaine , Yohan Gallois , Blandine Baladi Journal of Cystic Fibrosis, 2023, pp.1-5. ⟨10.1016/j.jcf.2023.04.002⟩ Article dans une revue hal-04086358v1
	Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades Peggy Gandia , Sarah Decheiver , Manon Picard , Romain Guilhaumou , Sarah Baklouti Antibiotics, 2023, 12 (3), pp.515. ⟨10.3390/antibiotics12030515⟩ Article dans une revue hal-04061765v1
	“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring Sarah Baklouti , Peggy Gandia , Didier Concordet Clinical Pharmacokinetics, 2022, 61 (5), pp.749 - 757. ⟨10.1007/s40262-021-01105-y⟩ Article dans une revue hal-03670618v1
	Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model? Sarah Baklouti , S. Marolleau , P. Chavanet , E. Bonnet , Didier Concordet Antimicrobial Agents and Chemotherapy, 2022, 66 (1), ⟨10.1128/AAC.01493-21⟩ Article dans une revue hal-03578727v1
	Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age Stella Rousset , Margaux Lafaurie , Hélène Guet-Revillet , Caroline Protin , Jean Le Grusse Drugs and Aging, 2021, 38 (1), pp.43-52. ⟨10.1007/s40266-020-00811-9⟩ Article dans une revue hal-03158686v1
	Maraviroc exposure is influenced by exogenous thyrotoxicosis David Metsu , Christian Aquilina , Pierre Delobel , Peggy Gandia , Frédérique Savagner AIDS. Official journal of the international AIDS Society, 2021, 35 (4), pp.701-703. ⟨10.1097/QAD.0000000000002754⟩ Article dans une revue hal-03473015v1
	Efficacy of dihydroartemisinin/piperaquine in patients with noncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon Mélissa Mairet-Khedim , Sandrine Nsango , Christelle Ngou , Sandie Menard , Camille Roesch Journal of Antimicrobial Chemotherapy, 2021, 76 (11), pp.3037-3044. ⟨10.1093/jac/dkab281⟩ Article dans une revue pasteur-03494748v1
	Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure Francoise Stanke-Labesque , Didier Concordet , Zoubir Djerada , Stephane Bouchet , Caroline Solas Clinical Pharmacology and Therapeutics, 2021, Therapeutic Innovations in Infectious Diseases, 109 (4), pp.1030-1033. ⟨10.1002/cpt.2196⟩ Article dans une revue hal-03191652v1
	Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection Midas B Mulder , Robert A Man , Nassim Kamar , Gűlcan Durmaz , Joep Bruijne Journal of Viral Hepatitis, 2021, 28 (2), pp.431-435. ⟨10.1111/jvh.13432⟩ Article dans une revue hal-03580025v1
	Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation Arnaud del Bello , Clotilde Gaible , Nathalie Longlune , Anne-Laure Hebral , Lauren Esposito Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.602764⟩ Article dans une revue hal-03623073v1
	Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations Eloise Baudou , Anne Lespine , Geneviève Durrieu , François André , Peggy Gandia New England Journal of Medicine, 2020, 383 (8), pp.787--789. ⟨10.1056/NEJMc1917344⟩ Article dans une revue hal-02928174v1
	Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics Guillaume Martin-Blondel , Stéphanie Ruiz , Marlene Murris , Stanilas Faguer , Véronigue Duhalde Clinical Infectious Diseases, 2020, 71 (11), pp.2962-2964. ⟨10.1093/cid/ciaa558⟩ Article dans une revue hal-03167732v1
	Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach David Metsu , Thomas Lanot , François Fraissinet , Didier Concordet , Véronique V. Gayrard-Troy Scientific Reports, 2020, 10 (1), ⟨10.1038/s41598-020-69102-y⟩ Article dans une revue hal-02911804v1
	Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study Camille Mané , Clément Delmas , Jean Porterie , Géraldine Jourdan , Patrick Verwaerde Journal of Translational Medicine, 2020, 18 (1), ⟨10.1186/s12967-020-02381-1⟩ Article dans une revue hal-02940915v1
	Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach Théo Willeman , Julia Tonini , Cécile Garnaud , Sébastien Bailly , Peggy Gandia Fundamental & Clinical Pharmacology, 2019, ⟨10.1111/fcp.12507⟩ Article dans une revue hal-02976876v1
	Memory impairment following intentional self-poisoning with benzodiazepines Juliette Salles , Jérémie Pariente , Laurent Schmitt , Dominique Lauque , Thomas Lanot Journal of Psychopharmacology, 2019, 33 (11), pp.1428-1435. ⟨10.1177/0269881119867609⟩ Article dans une revue hal-03641012v1
	Suicide Attempts Juliette Salles , Bernard Tiret , Adeline Gallini , Peggy Gandia , Christophe Arbus Suicide and Life-Threatening Behavior, 2019, 50 (1), pp.315-328. ⟨10.1111/sltb.12586⟩ Article dans une revue hal-03464218v1
	Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods David Metsu , Thomas Lanot , François Fraissinet , Mélanie Picot , Didier Concordet Clinica Chimica Acta, 2018, 479, pp.56-65. ⟨10.1016/j.cca.2017.12.034⟩ Article dans une revue hal-02621511v1
	Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle? David Metsu , Pierre-Louis Toutain , Etienne Chatelut , Pierre Delobel , Peggy Gandia Journal of Antimicrobial Chemotherapy, 2017, 72 (9), pp.2407-2409. ⟨10.1093/jac/dkx176⟩ Article dans une revue hal-01608734v1
	Population pharmacokinetics of tracers: A new tool for medical imaging? Peggy Gandia , Cyril Jaudet , Etienne Chatelut , Didier Concordet Clinical Pharmacokinetics, 2017, 56 (2), pp.101-106. ⟨10.1007/s40262-016-0437-9⟩ Article dans une revue hal-01607048v1
	Population pharmacokinetic approach applied to positron emission tomography: Computed tomography for tumor tissue identification in patients with glioma Peggy Gandia , Cyril Jaudet , Hendrik Everaert , Johannes Heemskerk , Anne Marie Vanbinst Clinical Pharmacokinetics, 2017, 56 (8), pp.953-961. ⟨10.1007/s40262-016-0490-4⟩ Article dans une revue hal-01601882v1
	Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring? David Metsu , Patrick Séraissol , Pierre Delobel , Christel Cinq-Frais , Lise Cuzin Fundamental & Clinical Pharmacology, 2017, ⟨10.1111/fcp.12245⟩ Article dans une revue hal-01907438v1
	Quinine unbound concentration is the best marker for therapeutic drug monitoring. Carlos de Pablos-Martinez , Lydie Porte , François Fraissinet , Antoine Berry , Patrick Séraissol Thérapie, 2016, 71 (5), pp.487-489. ⟨10.1016/j.therap.2016.02.032⟩ Article dans une revue hal-01601653v1
	Quinine unbound concentration has to be used for therapeutic drug monitoring. Carlos de Pablos-Martinez , Lydie Porte , François Fraissinet , Antoine Berry , Patrick Séraissol Therapeutic Drug Monitoring, 2016, 38 (4), pp.556-7. ⟨10.1097/FTD.0000000000000304⟩ Article dans une revue hal-02634648v1
	Problèmes et difficultés rencontrés lors de la planification et de l'analyse d'un essai de bioéquivalence. Pierre-Louis Toutain , Peggy Gandia , Alain Bousquet‐mélou La Lettre du Pharmacologue, 2014, 28 (2), pp.37-50 Article dans une revue hal-02630493v1
	Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships. Aurélie Prémaud , Annick Rousseau , Gyasi Johnson , Cindy Canivet , Peggy Gandia Pharmacological Research, 2011, 63 (5), pp.432-8. ⟨10.1016/j.phrs.2011.01.005⟩ Article dans une revue inserm-00926481v1
	Clomipramine in breast milk: a case study D Khachman , Peggy Gandia , Ma Gaillard , P Seraissol , P Mendousse Journal de Pharmacie Clinique, 2009, pp.33-38 Article dans une revue hal-02654422v1
	Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome. Cindy Canivet , Lionel Rostaing , Sylvain Galvani , Torsten Böhler , Peggy Gandia International Immunopharmacology, 2009, 9 (9), pp.1131-6. ⟨10.1016/j.intimp.2009.05.004⟩ Article dans une revue inserm-00410375v1
	Transfer of benzodiazepines into breast milk: clinical and analytical aspects D Khachman , Peggy Gandia , F Sena , C Tortissier , P Seraissol Annale de Toxicologie Analytique, 2008, pp.165-179 Article dans une revue hal-02661242v1
	Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nassim Kamar , Isabelle Gennero , Luciana Spataru , Laure Esposito , Joelle Guitard Nephrology Dialysis Transplantation, 2008, 23 (11), pp.3720-6. ⟨10.1093/ndt/gfn345⟩ Article dans une revue inserm-00409076v1
	Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter. Guylène Lafforgue , Cécile Arellano , Christelle Vachoux , John Woodley , Claude Philibert Fundamental & Clinical Pharmacology, 2008, 22 (2), pp.189-201. ⟨10.1111/j.1472-8206.2008.00572.x⟩ Article dans une revue hal-00517537v1

	Exploring of primary brains tumor heterogeneity at a voxel level with dynamic 18F-fluoro-ethyl-tyrosine (18F-FET) positon emission tomography Cyril Jaudet , Peggy Gandia , Henrik Everaert , Rémi Servien , J.W. Heemskerk Congress of the Radiological Sociey of North-America (RSNA), Nov 2015, Chicago, United States. pp.NM219-SD-TUA8 Communication dans un congrès hal-03277832v1

	Influence of ribavirin plasma concentration on the virological response and safety in patients with HCV genotype 1 infection treated by combination therapy with telaprevir or boceprevir Marie Julia , Peggy Gandia , Mathieu Guivarch , Laura Coimet-Berger , Florence Abravanel The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2014, Nov 2014, Boston, United States. Poster de conférence hal-03266134v1

	TOXICITE des AMINOSIDES - MODELISATION PK/PD Peggy Gandia Master. France. 2022 Cours hal-03853461v1
	ANESTHESIE GENERALE - MODELISATION PK/PD Peggy Gandia Master. France. 2022 Cours hal-03853444v1
	ANTIBIOTIQUES et EFFICACITE MICROBIOLOGIQUE Peggy Gandia Master. France. 2022 Cours hal-03853511v1
	CONCEPTS FONDAMENTAUX en MODELISATION PHARMACOCINETIQUE-PHARMACODYNAMIQUE Peggy Gandia Master. France. 2022 Cours hal-03848538v1
	ANTIHYPERTENSEURS - MODELISATION PK/PD Peggy Gandia Master. France. 2022 Cours hal-03854659v1

Peggy GANDIA

Présentation

Publications

Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis

Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades

“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring

Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?

Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age

Maraviroc exposure is influenced by exogenous thyrotoxicosis

Efficacy of dihydroartemisinin/piperaquine in patients with noncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon

Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation

Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations

Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics

Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach

Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study

Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach

Memory impairment following intentional self-poisoning with benzodiazepines

Suicide Attempts

Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods

Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?

Population pharmacokinetics of tracers: A new tool for medical imaging?

Population pharmacokinetic approach applied to positron emission tomography: Computed tomography for tumor tissue identification in patients with glioma

Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?

Quinine unbound concentration is the best marker for therapeutic drug monitoring.

Quinine unbound concentration has to be used for therapeutic drug monitoring.

Problèmes et difficultés rencontrés lors de la planification et de l'analyse d'un essai de bioéquivalence.

Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.

Clomipramine in breast milk: a case study

Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.

Transfer of benzodiazepines into breast milk: clinical and analytical aspects

Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.

Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter.

Exploring of primary brains tumor heterogeneity at a voxel level with dynamic 18F-fluoro-ethyl-tyrosine (18F-FET) positon emission tomography

Influence of ribavirin plasma concentration on the virological response and safety in patients with HCV genotype 1 infection treated by combination therapy with telaprevir or boceprevir

TOXICITE des AMINOSIDES - MODELISATION PK/PD

ANESTHESIE GENERALE - MODELISATION PK/PD

ANTIBIOTIQUES et EFFICACITE MICROBIOLOGIQUE

CONCEPTS FONDAMENTAUX en MODELISATION PHARMACOCINETIQUE-PHARMACODYNAMIQUE

ANTIHYPERTENSEURS - MODELISATION PK/PD